Oscar Health, Inc. (NYSE:OSCR) Receives $12.07 Consensus PT from Analysts

Shares of Oscar Health, Inc. (NYSE:OSCR) have been given a consensus recommendation of “Strong Sell” by the nine ratings firms that are covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a sell recommendation and four have given a hold recommendation to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $12.0714.

A number of equities research analysts have recently weighed in on the company. Baird R W downgraded Oscar Health from a “strong-buy” rating to a “hold” rating in a report on Friday, July 25th. Wall Street Zen downgraded shares of Oscar Health from a “hold” rating to a “sell” rating in a report on Saturday, August 9th. UBS Group restated a “sell” rating and set a $11.00 target price (down previously from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Robert W. Baird reiterated a “neutral” rating and issued a $14.00 price target (down from $28.00) on shares of Oscar Health in a research report on Friday, July 25th. Finally, Piper Sandler cut their price target on Oscar Health from $14.00 to $13.00 and set a “neutral” rating for the company in a research note on Thursday, August 14th.

Oscar Health Trading Down 2.3%

Shares of NYSE:OSCR opened at $18.01 on Friday. Oscar Health has a 12-month low of $11.20 and a 12-month high of $22.78. The business has a 50 day moving average of $16.46 and a 200-day moving average of $15.33. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.26. The stock has a market cap of $4.66 billion, a PE ratio of -22.24 and a beta of 1.87.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, topping the consensus estimate of ($0.90) by $0.01. The business had revenue of $2.86 billion during the quarter, compared to analysts’ expectations of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The firm’s revenue for the quarter was up 29.0% compared to the same quarter last year. During the same period last year, the firm posted $0.20 EPS. As a group, equities research analysts forecast that Oscar Health will post 0.69 earnings per share for the current year.

Insider Activity

In related news, insider Mario Schlosser sold 395,000 shares of the firm’s stock in a transaction on Monday, September 22nd. The stock was sold at an average price of $18.43, for a total value of $7,279,850.00. Following the transaction, the insider owned 501,148 shares in the company, valued at approximately $9,236,157.64. This trade represents a 44.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 24.39% of the company’s stock.

Institutional Investors Weigh In On Oscar Health

A number of large investors have recently bought and sold shares of OSCR. LRI Investments LLC lifted its holdings in shares of Oscar Health by 377.9% during the 2nd quarter. LRI Investments LLC now owns 1,233 shares of the company’s stock worth $26,000 after acquiring an additional 975 shares during the period. Atlantic Union Bankshares Corp acquired a new position in Oscar Health during the second quarter valued at approximately $33,000. Jones Financial Companies Lllp raised its position in Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after purchasing an additional 2,242 shares in the last quarter. Strs Ohio bought a new stake in Oscar Health during the first quarter worth $30,000. Finally, Larson Financial Group LLC boosted its holdings in shares of Oscar Health by 83,733.3% in the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock valued at $33,000 after purchasing an additional 2,512 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.